These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28639230)

  • 1. Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications.
    Pea F
    Clin Pharmacokinet; 2018 Feb; 57(2):177-189. PubMed ID: 28639230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tissue penetration of antibiotics. Does the treatment reach the target site?].
    Lagler H; Zeitlinger M
    Med Klin Intensivmed Notfmed; 2014 Apr; 109(3):175-81. PubMed ID: 24691884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients.
    Mahmoudi L; Mohammadpour AH; Ahmadi A; Niknam R; Mojtahedzadeh M
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):285-91. PubMed ID: 23426530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.
    Pea F; Viale P; Furlanut M
    Clin Pharmacokinet; 2005; 44(10):1009-34. PubMed ID: 16176116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents.
    Blot SI; Pea F; Lipman J
    Adv Drug Deliv Rev; 2014 Nov; 77():3-11. PubMed ID: 25038549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
    Roberts JA; Lipman J
    Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.
    Roberts JA; Kirkpatrick CM; Roberts MS; Dalley AJ; Lipman J
    Int J Antimicrob Agents; 2010 Feb; 35(2):156-63. PubMed ID: 20018492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Throughput Intracellular Antimicrobial Susceptibility Testing of Legionella pneumophila.
    Chiaraviglio L; Kirby JE
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7517-29. PubMed ID: 26392509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic issues for antibiotics in the critically ill patient.
    Roberts JA; Lipman J
    Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.
    Nau R; Sörgel F; Prange HW
    Clin Pharmacokinet; 1998 Sep; 35(3):223-46. PubMed ID: 9784935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts on the use of antimicrobials in cats.
    Albarellos GA; Landoni MF
    Vet J; 2009 Jun; 180(3):304-16. PubMed ID: 18314361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we transfer pharmacokinetics/pharmacodynamics of antimicrobials into clinical practice?
    Scaglione F
    Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S40-2. PubMed ID: 26607342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interethnic differences in pharmacokinetics of antibacterials.
    Tsai D; Jamal JA; Davis JS; Lipman J; Roberts JA
    Clin Pharmacokinet; 2015 Mar; 54(3):243-60. PubMed ID: 25385446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimisation of antimicrobial dosing based on pharmacokinetic and pharmacodynamic principles.
    Hoo GSR; Liew YX; Kwa AL
    Indian J Med Microbiol; 2017; 35(3):340-346. PubMed ID: 29063877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis.
    Fujii M; Karumai T; Yamamoto R; Kobayashi E; Ogawa K; Tounai M; Lipman J; Hayashi Y
    Expert Opin Drug Metab Toxicol; 2020 May; 16(5):415-430. PubMed ID: 32238005
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection.
    Scaglione F; Paraboni L
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):479-90. PubMed ID: 16771624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
    Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics and pharmacodynamics of antibacterial agents: on account of febrile neutropenic patients].
    Garzón JR; Cuervo M S; Gómez R J; Cortés JA
    Rev Chilena Infectol; 2011 Dec; 28(6):537-45. PubMed ID: 22286676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial penetration into polymorphonuclear leukocytes and alveolar macrophages.
    Murdoch MB; Peterson LR
    Semin Respir Infect; 1991 Jun; 6(2):112-21. PubMed ID: 1771302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial therapy for chronic bacterial prostatitis.
    Perletti G; Marras E; Wagenlehner FM; Magri V
    Cochrane Database Syst Rev; 2013 Aug; (8):CD009071. PubMed ID: 23934982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.